Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 12.57% is in line with its 5-year average of 12.73%, around the middle of its 5-year range (8.77%–15.49%).
As of the fiscal period ended Friday, October 31, 2025. 0.04% above its 12-month average of 12.57%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
12.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
12.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
13.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
12.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
10.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
9.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
9.40%
CURRENT VS TTM AVG
+0.04%
CURRENT VS 3Y AVG
-7.35%
CURRENT VS 5Y AVG
-1.23%
CURRENT VS 10Y AVG
+18.27%
CURRENT VS 15Y AVG
+27.07%
CURRENT VS 20Y AVG
+33.79%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+47.36%
vs the sector median at left
Agilent Technologies, Inc.
Market Cap
$39.08B
Return on Invested Capital (ROIC)
12.57%
TTM Avg
12.57%
3Y Avg
13.57%
5Y Avg
12.73%
Market Cap
$38.68B
Return on Invested Capital (ROIC)
8.23%
TTM Avg
8.41%
3Y Avg
8.23%
5Y Avg
6.99%
Market Cap
$43.67B
Return on Invested Capital (ROIC)
3.12%
TTM Avg
3.25%
3Y Avg
5.37%
5Y Avg
7.01%
Market Cap
$44.10B
Return on Invested Capital (ROIC)
40.27%
TTM Avg
37.07%
3Y Avg
34.89%
5Y Avg
35.94%
Market Cap
$33.22B
Return on Invested Capital (ROIC)
5.69%
TTM Avg
6.03%
3Y Avg
3.95%
5Y Avg
3.95%
Market Cap
$32.40B
Return on Invested Capital (ROIC)
21.54%
TTM Avg
21.87%
3Y Avg
20.30%
5Y Avg
19.27%
Market Cap
$32.20B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
Market Cap
$30.74B
Return on Invested Capital (ROIC)
-13.41%
TTM Avg
-4.17%
3Y Avg
-0.53%
5Y Avg
0.76%
Market Cap
$30.72B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
8.56%
3Y Avg
8.37%
5Y Avg
9.38%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agilent Technologies, Inc. (A) | $39.08B | 12.57% | 12.57% | 13.57% | 12.73% |
| IQVIA Holdings Inc. (IQV)vs › | $38.68B | 8.23% | 8.41% | 8.23% | 6.99% |
| Humana Inc. (HUM)vs › | $43.67B | 3.12% | 3.25% | 5.37% | 7.01% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.10B | 40.27% | 37.07% | 34.89% | 35.94% |
| Medline Inc. (MDLN)vs › | $33.22B | 5.69% | 6.03% | 3.95% | 3.95% |
| Zoetis Inc. (ZTS)vs › | $32.40B | 21.54% | 21.87% | 20.30% | 19.27% |
| DexCom, Inc. (DXCM)vs › | $32.20B | 16.61% | 13.40% | 11.07% | 9.62% |
| Centene Corp. (CNC)vs › | $30.74B | -13.41% | -4.17% | -0.53% | 0.76% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.72B | 8.84% | 8.56% | 8.37% | 9.38% |
| ResMed Inc. (RMD)vs › | $30.60B | 19.56% | 18.66% | 17.73% | 16.77% |
ROIC
12.6%
ROE
19.9%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-10-31 | 12.57% |
| 2024-10-31 | 12.56% |
| 2023-10-31 | 13.65% |
| 2022-10-31 | 15.49% |
| 2021-10-31 | 13.32% |
| 2020-10-31 | 8.77% |
| 2019-10-31 | 11.78% |
| 2018-10-31 | 4.10% |
| 2017-10-31 | 9.72% |
| 2016-10-31 | 7.63% |
| 2015-10-31 | 7.32% |
| 2014-10-31 | 4.59% |
| 2013-10-31 | 3.26% |
| 2012-10-31 | 12.58% |
| 2011-10-31 | 14.05% |
| 2010-10-31 | 6.89% |
| 2009-10-31 | -3.21% |
| 2008-10-31 | 11.91% |
| 2007-10-31 | 9.44% |
| 2006-10-31 | 6.80% |
| 2005-10-31 | 1.47% |
| 2004-10-31 | 6.25% |
| 2003-10-31 | -16.40% |
| 2002-10-31 | -17.63% |
| 2001-10-31 | -11.06% |
| 2000-10-31 | 10.56% |
| 1999-10-31 | 7.41% |
| 1998-10-31 | 8.47% |
